跳至主要内容
临床试验/NL-OMON55466
NL-OMON55466已完成不适用

Evaluation of Heart Failure with preserved Ejection Fraction and peripheral microvascular dysfunction - HFpEF and peripheral microcirculation

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 2,278 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,278

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • HFpEF patients:
  • - HFpEF diagnosis based on ESC 2016 diagnostic criteria.
  • - Aged 60 years or older., Controls with diabetes mellitus:
  • - Diabets mellitus diagnosis based on World Health Organization 2006 criteria.
  • - Aged 60 years or older., Controls without DM:
  • - No diabets mellitus diagnosis based on World Health Organization 2006
  • - Aged 60 years or older.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • HFpEF patients:
  • - Inability to give informed consent.
  • - Contraindications for pupil dilation by ocular drips, which is needed for the
  • primary endpoint of this study assessed by flicker-light induced retinal vessel
  • reactivity: a history of acute glaucoma, previous allergic reaction to ocular
  • dilation drips. pregnancy or giving breastfeeding, current presence of
  • intraocular oil or gas after retinal detachment.
  • - Contraindication for flicker-light induced retinal vessel reactivity
  • assessment: history of photosensitive epilepsy.,
  • Controls with diabetes mellitus:
  • - A history of heart failure.
  • Controls without diabetes mellitus:
  • - A history of heart failure.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验